Description

PONAXEN 45MG (Ponatinib) is a third-generation, orally administered tyrosine kinase inhibitor (TKI) developed for the treatment of adult patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), particularly in cases where resistance or intolerance to prior TKI therapies has been observed. Its molecular design specifically addresses the limitations of earlier-generation TKIs by targeting a broad spectrum of BCR-ABL mutations, including the T315I mutation, which is notably associated with therapeutic resistance and poor prognosis in hematologic malignancies. Ponatinib exhibits potent inhibitory activity against both native and mutant forms of BCR-ABL, positioning it as a critical therapeutic option for patients who have exhausted conventional treatment alternatives.

Therapeutic Uses of PONAXEN 45MG (Ponatinib)

Ponatinib is indicated for the treatment of specific types of blood cancers characterized by the presence of the Philadelphia chromosome or resistance to other tyrosine kinase inhibitors. Its clinical applications include:

1. Chronic Myeloid Leukemia (CML):

   • Used in adult patients with chronic-phase, accelerated-phase, or blast-phase CML who are resistant or intolerant to previous TKI therapy.

   • Particularly effective in patients harboring the T315I mutation, which confers resistance to first- and second-generation TKIs such as imatinib, dasatinib, and nilotinib.

2. Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia (Ph+ ALL):

   • Indicated for adult patients with relapsed or refractory Ph+ ALL, where other treatment options have failed or resistance has developed.

   • Offers an effective alternative for those with mutations in the BCR-ABL gene, including T315I.

3. Patients with the T315I Mutation:

   • Ponatinib is one of the few targeted therapies that demonstrate potent inhibition of BCR-ABL T315I, a mutation that renders most other TKIs ineffective.

4. Post-TKI Resistance or Intolerance:

   • Utilized as a salvage therapy for patients who have developed resistance or intolerance to two or more prior TKIs.

Side Effects

Can PONAXEN 45MG (Ponatinib) tablet Buy in Pakistan?

Yes, you can buy Ponaxen 45mg tablet in Pakistan from one of the most reliable and trusted online pharmacy Dawailo.pk. Order now and get you medicine delivered at your door step safely and securely.